V024-2686 Screening compound: 1-({1-benzyl-2-[(4-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-3-ethyl-1-(2-methylpropyl)urea

V024-2686 Screening compound: 1-({1-benzyl-2-[(4-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-3-ethyl-1-(2-methylpropyl)urea
V024-2686 Screening compound: 1-({1-benzyl-2-[(4-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-3-ethyl-1-(2-methylpropyl)urea alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-2686
1-({1-benzyl-2-[(4-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-3-ethyl-1-(2-methylpropyl)urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-2686

Molecular Formula

C26H34N4O3S (C26 H34 N4 O3 S)

Compound Name

1-({1-benzyl-2-[(4-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-3-ethyl-1-(2-methylpropyl)urea

IUPAC name

1-({1-benzyl-2-[(4-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-3-ethyl-1-(2-methylpropyl)urea

SMILES

CCNC(N(CC(C)C)Cc(n1Cc2ccccc2)cnc1S(Cc1ccc(C)cc1)(=O)=O)=O

InChI

InChI=1S/C26H34N4O3S/c1-5-27-25(31)29(16-20(2)3)18-24-15-28-26(30(24)17-22-9-7-6-8-10-22)34(32,33)19-23-13-11-21(4)12-14-23/h6-15,20H,5,16-19H2,1-4H3,(H,27,31)

InChI Key

WQRRSXQGYVLXOI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19819676

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

482.65

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.399

Distribution Coefficient, logD

4.399

Water Solubility, LogSw

-4.00

Polar Surface Area

66.903

Acid Dissociation Constant (pKa)

16.83

Base Dissociation Constant (pKb)

2.87

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

V024-2686 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

KRAS-Targeted Library (16000 compounds)

Anti-HIV1 Library (19540 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V024-2686 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-2686?
Check Price and Availability of V024-2686, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-2686 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-2686
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-2686
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-2686 available by request